Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
    • Our Story
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • ESG
  • News & Media
  • Contact
  • Menu Menu

Gate2Brain as alumni at Caixa Impulse Validate

Events
CaixaImpuls

On Monday 4th of October, Gate2Brain gave a talk at the Caixa Impulse Validate session. An acceleration program that provides support to early-stage biomedical research projects to help them validate their asset and define their valorization plan.

Two years ago, Gate2Brain was at this same session as an early-stage biotech being part of the program. Today, our CEO, Meritxell Teixidó, was invited alumni to explain Gate2Brain’s initial steps in its entrepreneurial journey to bring medicines beyond barriers.

An excellent session of exchange and networking brewing talent and innovative projects.

October 6, 2021/by noticias
Tags: Biotech, CaixaImpulse, entrepreneurship, Startup
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2021/10/Meritxell-Caixa-Impuls.jpeg 496 1024 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2021-10-06 10:46:322021-10-06 10:53:06Gate2Brain as alumni at Caixa Impulse Validate
You might also like
Meritxell Teixidó (Gate2Brain, Medicines Beyond Barriers): “Utilitzem una nova tecnologia basada en pèptids per millorar el transport de fàrmacs al cervell”Meritxell Teixidó (Gate2Brain, Medicines Beyond Barriers): “We use a new technology based on peptides to improve the transport of drugs to the brain”
10 Top Biotech Startups to Watch in 2023StartUs10 Top Biotech Startups to Watch in 2023
EITHealth Catapult 2022eithealthGate2Brain semifinalist of EITHealth’s Catapult 2022
Biotech New Frontiers Award 2022Gate2BrainG2B awarded with Biotech New Frontiers 2022
Gate2Brain among the 5 Catalan startups that have obtained funding from EIC AcceleratorcanvaGate2Brain among the 5 Catalan startups that have obtained funding from EIC Accelerator
BioSpain2021Gate2Brain attending BioSpain 2021
It’s Gate2Brain second anniversary!! 🎂 The creativity, work and dedication of Gate2Brain's team can only be matched with its desire to bring medicines beyond barriers.Gate2BrainGate2Brain second anniversary
These 9 great medical ventures come from research institutions

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Gate2Brain Selected for the EU Business Hub Mission at World Health Expo Osaka 2026June 23, 2026 - 13:31
  • Gate2Brain to Participate in the Barcelona Deep Tech Summit 2025November 3, 2025 - 10:23
  • Gate2Brain at BioJapan 2025 — Enabling Innovative Brain Delivery SolutionsOctober 15, 2025 - 12:56
  • Gate2Brain turns 5!July 9, 2025 - 18:07
  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Gate2Brain attending BioSpain 2021BioSpain2021Pediatric Innovation Dayi4kidsPediatric Innovation Day
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}